CryoLife (NYSE: CRY) reported Q4 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $45 million versus the consensus estimate of $46.92 million.

For earnings history and earnings-related data on CryoLife (CRY) click here.